预约演示
Cuba Begins China Registration of Diabetic Ulcer Drug
2009-05-08
ChinaBio Today -- Cuban officials have begun the registration process in China for Heberprot-B, an innovative treatment for chronic diabetic ulcers in the extremities. Developed by Havana’s Center for Genetic Engineering and Biotechnology (CIGB), Heberprot-B is said to reduce the need for amputation by 50%. The drug underwent Cuban clinical trials in more than 300 patients, and has been approved for use there since 2006. More details...
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
-适应症
靶点
-药物
-生物医药百科问答
全新生物医药AI Agent 覆盖科研全链路，让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。